SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000950170-24-016669
Filing Date
2024-02-16
Accepted
2024-02-16 20:35:42
Documents
1
Period of Report
2024-02-16

Document Format Files

Seq Description Document Type Size
1 4 ownership.html 4  
1 4 ownership.xml 4 4170
  Complete submission text file 0000950170-24-016669.txt   5676
Mailing Address 171 OYSTER POINT BLVD., SUITE 500 SOUTH SAN FRANCISCO CA 94080
Business Address 171 OYSTER POINT BLVD., SUITE 500 SOUTH SAN FRANCISCO CA 94080 415-865-2066
Tenaya Therapeutics, Inc. (Issuer) CIK: 0001858848 (see all company filings)

IRS No.: 813789973 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)

Mailing Address C/O TENAYA THERAPEUTICS, INC. 171 OYSTER POINT BOULEVARD SOUTH SAN FRANCISCO CA 94080
Business Address
Tingley Whittemore (Reporting) CIK: 0001868494 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-40656 | Film No.: 24650346